Clark Capital Management Group, Inc.

Position in CRL — Charles River Laboratories International, Inc.

CIK 1352187 PHILADELPHIA, PA

Position in CRL

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$23,010,566

+$8,087,764 QoQ

Shares Held

101,462

+17.3% QoQ

Ownership

0.213%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#72

of 569 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Clark Capital Management Group, Inc. holds $76,790,892 across 4 Diagnostics & Research names. CRL ranks #2 (30.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DGX	Quest Diagnostics Inc	241,846	$51,259,259
2	CRL	Charles River Laboratories International, Inc. This page	101,462	$23,010,566
3	TMO	Thermo Fisher Scientific Inc.	4,087	$2,049,058
4	DHR	Danaher Corp /De/	2,478	$472,009

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,010,566	101,462	+17.3%	Shares	Sole	2026-08-11
2026-03-31	$14,922,802	86,509	+104.1%	Shares	Sole	2026-05-15
2025-12-31	$8,456,156	42,391	+1369.9%	Shares	Sole	2026-02-17
2022-12-31	$628,423	2,884	-4.5%	Shares	Sole	2023-02-14
2022-09-30	$594,139	3,019	+2.4%	Shares	Sole	2022-11-14
2022-06-30	$630,783	2,948	-97.2%	Shares	Sole	2022-08-15
2022-03-31	$29,841,271	105,086	+77.8%	Shares	Sole	2022-05-16
2021-12-31	$22,264,683	59,092	-30.0%	Shares	Sole	2022-02-14
2021-09-30	$34,840,077	84,426	-7.0%	Shares	Sole	2021-11-15
2021-06-30	$33,576,898	90,768	-15.4%	Shares	Sole	2021-08-02
2021-03-31	$31,107,743	107,331	-9.7%	Shares	Sole	2021-05-17
2020-12-31	$29,691,613	118,833	-4.6%	Shares	Sole	2021-01-26
2020-09-30	$28,217,934	124,610	+5.0%	Shares	Sole	2020-11-12
2020-06-30	$20,693,427	118,689	-37.0%	Shares	Sole	2020-08-14
2020-03-31	$23,765,343	188,300	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.